BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17214786)

  • 1. MBI: M(I)BI agonistes or a new chapter?
    Brenner RJ
    Breast J; 2007; 13(1):1-2. PubMed ID: 17214786
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multifocal breast neoplasm with bone involvement].
    Blocklet D; Seret A; Schoutens A
    Rev Med Brux; 1998 Dec; 19(6):A501-2. PubMed ID: 9916497
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nuclear oncology update].
    Maublant J; Resche I; Giammarile F; Corone C; Artus JC
    Bull Cancer; 1999 Jan; 86(1):57-64. PubMed ID: 10029706
    [No Abstract]   [Full Text] [Related]  

  • 4. The importance of patient positioning in the detection of axillary lymphatic involvement with Tc-99m sestamibi scintimammography.
    Arslan N; Ozturk E; Ilgan S; Bayhan H
    Clin Nucl Med; 1999 Nov; 24(11):884-5. PubMed ID: 10551474
    [No Abstract]   [Full Text] [Related]  

  • 5. Technetium-99m-sestamibi imaging in breast cancer: an alternative to thallium-201 imaging.
    Aktolun C
    J Nucl Med; 1994 Dec; 35(12):2055-6. PubMed ID: 7989994
    [No Abstract]   [Full Text] [Related]  

  • 6. A perspective on decision analysis modeling as it relates to sestamibi imaging of nonpalpable breast abnormalities.
    Waxman AD
    J Nucl Med; 1997 Nov; 38(11):1778-80. PubMed ID: 9374353
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
    Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK
    J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of 99mTc-MIBI image axillary lymph node in selecting operative method for breast cancer].
    Qu X; Wang Y; Chen D; Li C
    Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):41-3. PubMed ID: 11829776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult breast cancer detection with technetium-99m-sestamibi: a case report.
    Park YH; Ferrante J; Robinson RE; Arvay K
    J Nucl Med Technol; 1999 Dec; 27(4):298-300. PubMed ID: 10646550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of axillary lymph node metastasis of breast carcinoma with technetium-99m sestamibi scintimammography.
    Tolmos J; Khalkhali I; Vargas H; Stuntz M; Cutrone J; Mishkin F; Diggles L; Venegas R; Klein S
    Am Surg; 1997 Oct; 63(10):850-3. PubMed ID: 9322655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast scintigraphy].
    Prats E; Razola P; García López F; Dolores Abós M; Banzo J
    Rev Esp Med Nucl; 2001 Feb; 20(1):47-70. PubMed ID: 11181333
    [No Abstract]   [Full Text] [Related]  

  • 13. Accuracy of ultrasonography and 99mTc-sestamibi scintimammography for assessing axillary lymph node status in breast cancer patients. A prospective study.
    Lumachi F; Tregnaghi A; Ferretti G; Povolato M; Marzola MC; Zucchetta P; Cecchin D; Bui F
    Eur J Surg Oncol; 2006 Nov; 32(9):933-6. PubMed ID: 16797155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tc-99m sestamibi exam finds niche in breast Dx.
    Chen EM; Khalkhali I; Cutrone JA; Diggles LE; Mishkin F
    Diagn Imaging (San Franc); 1997 Aug; 19(8):61-5. PubMed ID: 10169379
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of patient positioning in scintimammography.
    Mirzaei S; Knoll P; Köhn H; Lipp RW; Zajicek SM
    Eur J Nucl Med; 2001 Sep; 28(9):1437-8. PubMed ID: 11585308
    [No Abstract]   [Full Text] [Related]  

  • 16. Tc-99m sestamibi scintimammography: where is it now?
    Schillaci O; Scopinaro F
    Cancer Biother Radiopharm; 1999 Dec; 14(6):417-22. PubMed ID: 10850328
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular Breast Imaging: A Comprehensive Review.
    Huppe AI; Mehta AK; Brem RF
    Semin Ultrasound CT MR; 2018 Feb; 39(1):60-69. PubMed ID: 29317040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of occult breast carcinoma during evaluation of a skeletal tumor by Tc-99m MIBI scintigraphy.
    Hod N; Mindlin L; Horne T
    Isr Med Assoc J; 2003 Apr; 5(4):296-7. PubMed ID: 14509141
    [No Abstract]   [Full Text] [Related]  

  • 19. [99m-Tc-Technetryle mammascintigraphy: clinical protocol and first experience in clinical diagnosis of breast cancer].
    Usov VI; Riannel' IE; Slonimskaia EM; Barta I; Bagameri I; Velichko SA
    Vestn Rentgenol Radiol; 1997; (5):12-7. PubMed ID: 9412042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invited commentary: one step forward.
    Lastoria S; Piccolo S; Muto P
    J Nucl Med; 2002 Jul; 43(7):916-7. PubMed ID: 12097462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.